Optimum Management of Nausea and Vomiting in Cancer Chemotherapy
- 1 July 1987
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 34 (1), 136-149
- https://doi.org/10.2165/00003495-198734010-00005
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects.Journal of Clinical Oncology, 1985
- The effect of administration rate on cisplatin-induced emesis.Journal of Clinical Oncology, 1985
- High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.Journal of Clinical Oncology, 1985
- Combination Antiemetic Therapy in the Control of Chemotherapy-Induced EmesisDrug Intelligence & Clinical Pharmacy, 1985
- Amitriptyline plus fluphenazine to prevent chemotherapy-induced emesis in cancer patients: a double-blind randomized cross-over studyEuropean Journal of Cancer and Clinical Oncology, 1984
- Optimizing Metoclopramide Control of Cisplatin-Induced EmesisAnnals of Internal Medicine, 1984
- The clinical application of chronobiology to oncologyJournal of Anatomy, 1983
- The Gastrointestinal Tract in Chemotherapy-induced EmesisDrugs, 1983
- A pilot investigation of the psychologic functioning of patients with anticipatory vomitingCancer, 1982
- The Control of Chemotherapy-Induced EmesisAnnals of Internal Medicine, 1981